Data mining the human gut microbiota for therapeutic targets

It is well known that microbes have an intricate role in human health and disease. However, targeted strategies for modulating human health through the modification of either human-associated microbial communities or associated human-host targets have yet to be realized. New knowledge about the role of microbial communities in the microbiota of the gastrointestinal tract (GIT) and their collective genomes, the GIT microbiome, in chronic diseases opens new opportunities for therapeutic interventions. GIT microbiota participation in drug metabolism is a further pharmaceutical consideration. In this review, we discuss how computational methods could lead to a systems-level understanding of the global physiology of the host-microbiota superorganism in health and disease. Such knowledge will provide a platform for the identification and development of new therapeutic strategies for chronic diseases possibly involving microbial as well as human-host targets that improve upon existing probiotics, prebiotics or antibiotics. In addition, integrative bioinformatics analysis will further our understanding of the microbial biotransformation of exogenous compounds or xenobiotics, which could lead to safer and more efficacious drugs.

[1]  S. Massart,et al.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa , 2010, Proceedings of the National Academy of Sciences.

[2]  Aleksandar Milosavljevic,et al.  Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. , 2011, Gastroenterology.

[3]  Johannes Söding,et al.  Fast and accurate automatic structure prediction with HHpred , 2009, Proteins.

[4]  K. Mills,et al.  Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. , 2011, The Journal of allergy and clinical immunology.

[5]  P. Brigidi,et al.  Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians , 2010, PloS one.

[6]  L. Rychlewski,et al.  Meta-basic estimates the size of druggable human genome , 2009, Journal of molecular modeling.

[7]  Ruth Ley,et al.  Unravelling the effects of the environment and host genotype on the gut microbiome , 2011, Nature Reviews Microbiology.

[8]  J. Gordon,et al.  Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. , 2008, Cell host & microbe.

[9]  G. Michel,et al.  Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota , 2010, Nature.

[10]  C. Probert,et al.  Identification and Characterisation of an Iron-Responsive Candidate Probiotic , 2011, PloS one.

[11]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[12]  Abdul W Basit,et al.  The gastrointestinal microbiota as a site for the biotransformation of drugs. , 2008, International journal of pharmaceutics.

[13]  Joel V Weinstock,et al.  Helminthic therapy: using worms to treat immune-mediated disease. , 2009, Advances in experimental medicine and biology.

[14]  R. Knight,et al.  Moving pictures of the human microbiome , 2011, Genome Biology.

[15]  Jonathan A. Eisen,et al.  PhylOTU: A High-Throughput Procedure Quantifies Microbial Community Diversity and Resolves Novel Taxa from Metagenomic Data , 2011, PLoS Comput. Biol..

[16]  E. Quigley,et al.  Gut microbiota and the role of probiotics in therapy. , 2011, Current opinion in pharmacology.

[17]  J. Gordon,et al.  Human nutrition, the gut microbiome and the immune system , 2011, Nature.

[18]  J. Kiley,et al.  Advancing respiratory research. , 2011, Chest.

[19]  S. Mazmanian,et al.  The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.

[20]  Michael Habeck,et al.  HHfrag: HMM-based fragment detection using HHpred , 2011, Bioinform..

[21]  A. Godzik.  Metagenomics and the protein universe. , 2011, Current opinion in structural biology.

[22]  Maria Karlsson,et al.  Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. , 2010, Cell host & microbe.

[23]  Matthew R. Redinbo,et al.  Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme , 2010, Science.

[24]  Ian D. Wilson,et al.  Metabolic Phenotyping in Health and Disease , 2008, Cell.

[25]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[26]  Mark Lyte,et al.  Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[27]  M. Blaser,et al.  Antibiotic overuse: Stop the killing of beneficial bacteria , 2011, Nature.

[28]  G. Moro,et al.  Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. , 2007, The Journal of nutrition.

[29]  Jacques Amar,et al.  Gut microbiota and diabetes: from pathogenesis to therapeutic perspective , 2011, Acta Diabetologica.

[30]  F. Bushman,et al.  Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags , 2010, BMC Microbiology.

[31]  B. Shenderov,et al.  Probiotic (symbiotic) bacterial languages. , 2011, Anaerobe.

[32]  John C Lindon,et al.  Pharmacometabonomics as an effector for personalized medicine. , 2011, Pharmacogenomics.

[33]  Pawel Kaleta,et al.  Comparative genomics of lactic acid bacteria reveals a niche-specific gene set , 2009, BMC Microbiology.

[34]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[35]  Ju-Hoon Lee,et al.  Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth , 2008, BMC Genomics.

[36]  Peer Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[37]  A. Valencia.  Automatic annotation of protein function. , 2005, Current opinion in structural biology.

[38]  W. Whitman,et al.  Prokaryotes: the unseen majority. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Jonathan A. Eisen,et al.  Human gut microbiome adopts an alternative state following small bowel transplantation , 2009, Proceedings of the National Academy of Sciences.

[40]  Lee Harland,et al.  Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery , 2009, Nature Reviews Drug Discovery.

[41]  John C. Wooley,et al.  Expansion of the Protein Repertoire in Newly Explored Environments: Human Gut Microbiome Specific Protein Families , 2010, PLoS Comput. Biol..

[42]  Philip Hugenholtz,et al.  Impact of Culture-Independent Studies on the Emerging Phylogenetic View of Bacterial Diversity , 1998, Journal of bacteriology.

[43]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[44]  Hiroshi Mori,et al.  Comparative Metagenomics Revealed Commonly Enriched Gene Sets in Human Gut Microbiomes , 2007, DNA research : an international journal for rapid publication of reports on genes and genomes.

[45]  R. Knight,et al.  Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. , 2009, Genome research.

[46]  Henrik Svanström,et al.  Antibiotic use and inflammatory bowel diseases in childhood , 2010, Gut.

[47]  J B L Hoekstra,et al.  The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus , 2012, Diabetes, obesity & metabolism.

[48]  James Versalovic,et al.  Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll‐like receptor 2‐knockout mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  K. Schleifer,et al.  Phylogenetic identification and in situ detection of individual microbial cells without cultivation. , 1995, Microbiological reviews.

[50]  N. Hall,et al.  Towards the Human Colorectal Cancer Microbiome , 2011, PloS one.

[51]  Jason H. Moore,et al.  Human Microbiome Visualization Using 3d Technology , 2011, Pacific Symposium on Biocomputing.

[52]  J. Neu,et al.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns , 2011 .

[53]  Matthew R. Pocock,et al.  Customizable views on semantically integrated networks for systems biology , 2011, Bioinform..

[54]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[55]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[56]  Kevin P. Keegan,et al.  Predicted Relative Metabolomic Turnover (PRMT): determining metabolic turnover from a coastal marine metagenomic dataset , 2011, Microbial Informatics and Experimentation.

[57]  Adam M. Phillippy,et al.  Interactive metagenomic visualization in a Web browser , 2011, BMC Bioinformatics.

[58]  N. Pace,et al.  Disease phenotype and genotype are associated with shifts in intestinal‐associated microbiota in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.

[59]  Fabian Schreiber,et al.  CoMet—a web server for comparative functional profiling of metagenomes , 2011, Nucleic Acids Res..

[60]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[61]  M. Icaza-Chávez,et al.  Gut microbiota in health and disease , 2013 .

[62]  Lu Wang,et al.  The NIH Human Microbiome Project. , 2009, Genome research.

[63]  T. Marshall,et al.  Immunostimulation in the era of the metagenome , 2011, Cellular and Molecular Immunology.

[64]  Les Dethlefsen,et al.  The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.

[65]  Jeramie D Watrous,et al.  Integrating '-omics' and natural product discovery platforms to investigate metabolic exchange in microbiomes. , 2011, Current opinion in chemical biology.

[66]  B. Haas,et al.  A Catalog of Reference Genomes from the Human Microbiome , 2010, Science.

[67]  R. Knight,et al.  Postprandial remodeling of the gut microbiota in Burmese pythons , 2010, The ISME Journal.

[68]  S. Dusko Ehrlich,et al.  MetaHIT: The European Union Project on Metagenomics of the Human Intestinal Tract , 2011 .

[69]  R. Knight,et al.  Forensic identification using skin bacterial communities , 2010, Proceedings of the National Academy of Sciences.

[70]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[71]  Patrice D Cani,et al.  The gut microbiome as therapeutic target. , 2011, Pharmacology & therapeutics.

[72]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[73]  Min Zhang,et al.  The Evolution of Host Specialization in the Vertebrate Gut Symbiont Lactobacillus reuteri , 2011, PLoS genetics.

[74]  Mihai Pop,et al.  Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples , 2009, PLoS Comput. Biol..

[75]  Clara Abraham,et al.  Interactions between the host innate immune system and microbes in inflammatory bowel disease. , 2011, Gastroenterology.

[76]  Levi Waldron,et al.  Metagenomic biomarker discovery and explanation , 2011 .

[77]  H. Okuda,et al.  A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. , 1998, The Journal of pharmacology and experimental therapeutics.

[78]  Jonathan A. Eisen,et al.  The Phylogenetic Diversity of Metagenomes , 2011, PloS one.

[79]  C. Bulpitt,et al.  Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial , 2007, BMJ : British Medical Journal.

[80]  P J Ciclitira,et al.  Review article: faecal transplantation therapy for gastrointestinal disease , 2011, Alimentary pharmacology & therapeutics.

[81]  Kenneth Fiske Boorom,et al.  Is this recently characterized gastrointestinal pathogen responsible for rising rates of inflammatory bowel disease (IBD) and IBD associated autism in Europe and the United States in the 1990s? , 2007, Medical hypotheses.

[82]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[83]  Karin Dahlman-Wright,et al.  From DNA binding to metabolic control: integration of ‐omics data reveals drug targets for prostate cancer , 2011, The EMBO journal.

[84]  Andreas Wilke,et al.  phylogenetic and functional analysis of metagenomes , 2022 .

[85]  José A. B. Fortes,et al.  CloudBLAST: Combining MapReduce and Virtualization on Distributed Resources for Bioinformatics Applications , 2008, 2008 IEEE Fourth International Conference on eScience.

[86]  James R. Brown,et al.  Computational biology approaches for selecting host-pathogen drug targets. , 2011, Drug discovery today.

[87]  Karen E. Nelson,et al.  Metagenomics of the human body , 2011 .

[88]  Matthew R. Pocock,et al.  A grid-based system for microbial genome comparison and analysis , 2005, CCGrid 2005. IEEE International Symposium on Cluster Computing and the Grid, 2005..

[89]  Gilbert Habib,et al.  Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity , 2010, PloS one.

[90]  Peter van Baarlen,et al.  Epithelial crosstalk at the microbiota–mucosal interface , 2010, Proceedings of the National Academy of Sciences.

[91]  F. Shanahan,et al.  The gut flora as a forgotten organ , 2006, EMBO reports.

[92]  H. Tettelin,et al.  The microbial pan-genome. , 2005, Current opinion in genetics & development.

[93]  ERGUS SHANAHAN,et al.  Perspectives robiotics in Perspective , 2010 .

[94]  Rima Kaddurah-Daouk,et al.  Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment , 2011, PloS one.

[95]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[96]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[97]  D. Savage.  Microbial ecology of the gastrointestinal tract. , 1977, Annual review of microbiology.

[98]  Mihai Pop,et al.  MetaPath: identifying differentially abundant metabolic pathways in metagenomic datasets , 2011, BMC proceedings.

[99]  W. R. Wikoff,et al.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites , 2009, Proceedings of the National Academy of Sciences.

[100]  D. Elliott,et al.  Helminths and the IBD hygiene hypothesis , 2009, Inflammatory bowel diseases.

[101]  H. Moi,et al.  The genital econiche: focus on microbiota and bacterial vaginosis , 2011, Annals of the New York Academy of Sciences.

[102]  Shailesh V. Date,et al.  A Probabilistic Functional Network of Yeast Genes , 2004, Science.

[103]  R. Wilson,et al.  Evolution of Symbiotic Bacteria in the Distal Human Intestine , 2007, PLoS biology.

[104]  Dirk Haller,et al.  Bacterial proteases in IBD and IBS , 2011, Gut.

[105]  Matthew R. Pocock,et al.  An integrated dataset for in silico drug discovery , 2010, J. Integr. Bioinform..

[106]  A. Macpherson,et al.  Immune adaptations that maintain homeostasis with the intestinal microbiota , 2010, Nature Reviews Immunology.

[107]  Alexander F. Auch,et al.  MEGAN analysis of metagenomic data. , 2007, Genome research.

[108]  G. Trinchieri,et al.  Innate immune mechanisms of colitis and colitis-associated colorectal cancer , 2011, Nature Reviews Immunology.

[109]  Paul Knight,et al.  Host-bacteria interaction in inflammatory bowel disease. , 2008, British medical bulletin.

[110]  B. Finlay,et al.  The role of the immune system in regulating the microbiota , 2010, Gut microbes.

[111]  Rob Knight,et al.  Host-bacterial coevolution and the search for new drug targets. , 2008, Current opinion in chemical biology.

[112]  王林,et al.  GoPubmed , 2010 .

[113]  S Falkow,et al.  Molecular Koch's postulates applied to microbial pathogenicity. , 1988, Reviews of infectious diseases.

[114]  Monique Alric,et al.  In vitro maintenance of a human proximal colon microbiota using the continuous fermentation system P-ECSIM , 2011, Applied Microbiology and Biotechnology.

[115]  Rob Knight,et al.  Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation , 2009, Proceedings of the National Academy of Sciences.

[116]  Ian D Wilson,et al.  Drugs, bugs, and personalized medicine: Pharmacometabonomics enters the ring , 2009, Proceedings of the National Academy of Sciences.

[117]  C. Bernstein,et al.  Association Between the Use of Antibiotics and New Diagnoses of Crohn's Disease and Ulcerative Colitis , 2011, The American Journal of Gastroenterology.

[118]  Rob Knight,et al.  UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context , 2006, BMC Bioinformatics.

[119]  James Versalovic,et al.  Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. , 2009, Gastroenterology.